Sanofi

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:35:55 2024-05-10 am EDT			5-day change	1st Jan Change
94.33 ^EUR	+1.23%		+3.32%	+5.09%

May. 10	News Highlights : Top Company News of the Day - Friday at 7 PM ET	DJ
May. 10	Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup	DJ

SANOFI : Credit Suisse maintains a Buy rating

January 20, 2023 at 08:23 am EST

In a research note published by Dominic Lunn, Credit Suisse advises its customers to buy the stock. The target price remains set at EUR 114.

Latest news about Sanofi

News Highlights : Top Company News of the Day - Friday at 7 PM ET	May. 10	DJ
Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup	May. 10	DJ
US Equity Markets Close Mixed Friday After Consumer Sentiment Falls	May. 10	MT
Sector Update: Health Care Stocks Higher Late Afternoon	May. 10	MT
News Highlights : Top Company News of the Day - Friday at 3 PM ET	May. 10	DJ
Novavax shares soar on license deal with Sanofi	May. 10	RE
Sector Update: Health Care Stocks Advance Friday Afternoon	May. 10	MT
Wall St mixed but headed for weekly gains ahead of inflation data	May. 10	RE
Top MIdday Gainers	May. 10	MT
Sector Update: Health Care	May. 10	MT
News Highlights : Top Company News of the Day - Friday at 1 PM ET	May. 10	DJ
Top Midday Stories: Biden to Reportedly Quadruple Chinese EV Tariffs; Novavax Shares Soar on Sanofi Deal News; Protesters Try to Break Into Tesla's Plant in Germany; FDA Pushes Back Approval of Moderna Vaccine	May. 10	MT
CAC40: Signs new records, weekly gain of +3	May. 10	CF
CAC40: beats record despite rising rates and indecisive W-Street	May. 10	CF
Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi	May. 10	MT
News Highlights : Top Company News of the Day - Friday at 11 AM ET	May. 10	DJ
CAC40: new all-time high (8,257), after DAX, AEX, FT-100	May. 10	CF
Novavax Unveils COVID-19 Vaccine Licensing Deal With Sanofi; Shares Soar	May. 10	MT
Wall St gains ahead of Fed officials' remarks; Dow nears 40,000 mark	May. 10	RE
Trending : Sanofi, Novavax to Develop New Covid-19 Vaccines	May. 10	DJ
Sector Update: Health Care Stocks Edge Higher Premarket Friday	May. 10	MT
Sector Update: Health Care	May. 10	MT
Wall Street Set to Extend Gains on Thursday's Higher-Than-Expect Jobless Claims Report, Lifting US Equity Futures Pre-Bell	May. 10	MT
SANOFI : UBS gives a Buy rating	May. 10	ZD
HEDGE FUND SHAH CAPITAL SAYS NOVAVAX-SANOFI DEAL IS "A STEP IN T…	May. 10	RE

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).

Sector

Pharmaceuticals

Calendar

2024-05-12 - Ex-dividend day for final dividend

Related indices

CAC 40 , EURO STOXX 50 , STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

SANOFI : Sanofi’s healthy Q1 performance hailed by markets

April 25, 2024 at 07:58 am EDT

Sanofi Sees Trend for Years of Steady Growth: CFO

February 03, 2023 at 03:56 pm EST

More Strategies

Ratings for Sanofi

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

94.33 EUR

Average target price

108.1 EUR

Spread / Average Target

+14.56%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SANOFI	+5.09%	127B
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals

Sanofi

Equities

SAN

FR0000120578

Pharmaceuticals

SANOFI : Credit Suisse maintains a Buy rating

Latest news about Sanofi

Chart Sanofi

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Sanofi

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals